OrbiMed Capital GP VIII LLC

DirectorSionna Therapeutics, Inc. (SION) · full profile →Form 4 · filed Dec 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$83K
Net Open-Market Flow
-$83K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 19, 2025Sell(S)875$44.49$39K3.6M
Dec 18, 2025Sell(S)100$44.49$4K3.6M
Dec 17, 2025Sell(S)900$44.50$40K3.6M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-25-001088) within minutes of acceptance. Every field above traces to the original document. Verify it directly: